AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (December 4, 2001). doi:10.1152/ajpendo.00111.2001
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/4/E746    most recent
00111.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ling, S.
Right arrow Articles by Sudhir, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ling, S.
Right arrow Articles by Sudhir, K.

Articles in PresS, published online ahead of print December 4, 2001
Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00111.2001
Submitted on March 9, 2001
Accepted on November 14, 2001

High glucose abolishes the antiproliferative effect of 17ß -estradiol in human vascular smooth muscle cells

Shanhong Ling1, Peter J Little2, Maro R Williams1, Aozhi Dai1, Kazuhiko Hashimura1, Jun-Ping Liu3, Paul A Komesaroff1, and Krishnankutty Sudhir1*

1 Hormones and the Vasculature Laboratory, Baker Medical Research Institute, Melbourne, Australia
2 Cell Biology of Diabetes Laboratory, Baker Medical Research Institute, Melbourne, Australia
3 Molecular Signaling Laboratory, Baker Medical Research Institute, Melbourne, Australia

* To whom correspondence should be addressed. E-mail: ksudhir{at}pcyc.com.

We examined effects of 17ß-estradiol (E2) on human vascular smooth muscle cell (VSMC) proliferation under normal (5 mmol/L) and high (25 mmol/L) glucose concentrations. Platelet-derived growth factor (PDGF) BB (20 ng/mL)- induced increases in DNA synthesis and proliferation were greater in high than normal glucose concentrations; the difference in DNA synthesis was abolished by a protein kinase C (PKC) -ß inhibitor LY379196 (30 nmol/L). Western blotting showed that PKC-ß1 protein increased in cells exposed to high glucose, while PKC-{alpha} protein and total PKC activity remained unchanged, in comparison with normal glucose cultures. In normal glucose, E2(1-100 nmol/L) inhibited PDGF- induced DNA synthesis by 18-37% and cell proliferation by 16-22% in a concentration-dependent manner. The effects of E2 were blocked by the ER antagonist ICI 182780, indicating ER-dependence. In high glucose, the inhibitory effect of E2 on VSMC proliferation was abolished, but restored in the presence of the PKC-ß inhibitor LY379196. Thus, high glucose enhances human VSMC proliferation and attenuates the antiproliferative effect of E2 in VSMC via activation of PKC-ß.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2001 by the American Physiological Society.